| Heading: |
Streptococcus: Testing |
| Question ID: |
1807660 |
| UIN: |
56092 |
| House: |
Commons |
| Date tabled: |
2025-05-30 |
| Asking Member ID: |
5283 |
| Asking Member display name: |
Alison Bennett
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Alison Bennett
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what information his Department holds on regional variations in access to group B Streptococcus testing; and what steps are being taken to reduce those variations. |
| Is named day: |
true |
| Date of holding answer: |
2025-06-05 |
| Date answered: |
2025-06-05 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The UK National External Quality Assessment Service’s (NEQAS) microbiology service, hosted by The UK Health Security Agency (UKHSA), has introduced a group B Streptococcus Screening External Quality Assessment scheme as of April 2025. The UKHSA does not c... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |